At the end of 2019 a novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), causing severe acute respiratory syndrome expanded globally from Wuhan, China …

The role of non-invasive respiratory support (high-flow nasal oxygen and noninvasive
ventilation) in the management of acute hypoxemic respiratory failure and acute respiratory …

The aim of these guidelines is to update the 2017 clinical practice guideline (CPG) of the
European Society of Intensive Care Medicine (ESICM). The scope of this CPG is limited to …

Importance High-flow nasal oxygen is recommended as initial treatment for acute hypoxemic
respiratory failure and is widely applied in patients with COVID-19. Objective To assess …

Over 200 years ago, René Laennec published the first description of emphysema, an
important pathobiological element of what is today known as chronic obstructive pulmonary …

Background High-flow nasal cannula (HFNC) has become a frequently used noninvasive
form of respiratory support in acute settings; however, evidence supporting its use has only …

Background The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
the cause of a rapidly spreading illness, Coronavirus Disease 2019 (COVID-19), affecting …

Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV)
infection is suspected Page 1 Clinical management of severe acute respiratory infection when …

Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is
suspected Page 1 -1- Clinical management of severe acute respiratory infection (SARI) when …

Background Spontaneous-breathing trials can be performed with the use of either pressure-
support ventilation (PSV) or a T-piece. Whether PSV trials may result in a shorter time to …